Literature DB >> 21219355

Plasma and tissue pharmacokinetics of danofloxacin in healthy and in experimentally infected chickens with Pasteurella multocida.

Z Zeng1, G Deng, X Shen, M Rizwan-Ul-Haq, D Zeng, H Ding.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21219355     DOI： 10.1111/j.1365-2885.2010.01223.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN： 0140-7783            Impact factor:   1.786


× No keyword cloud information.
  4 in total

1.  Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin.

Authors:  Nan Zhang; Xiaomei Ye; Yuzhi Wu; Zilong Huang; Xiaoyan Gu; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

2.  The PK-PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model.

Authors:  Nan Zhang; Yuzhi Wu; Zilong Huang; Lihua Yao; Longfei Zhang; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  Front Microbiol       Date:  2017-05-30       Impact factor: 5.640

3.  Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model.

Authors:  Nan Zhang; Yuzhi Wu; Zilong Huang; Chuanzhen Zhang; Longfei Zhang; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

4.  Susceptibility breakpoint for Danofloxacin against swine Escherichia coli.

Authors:  Yuqi Yang; Yixin Zhang; Jiarui Li; Ping Cheng; Tianshi Xiao; Ishfaq Muhammad; Hongxiao Yu; Ruimeng Liu; Xiuying Zhang
Journal:  BMC Vet Res       Date:  2019-02-04       Impact factor: 2.741
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.